Bennett, W.P., El-Deiry, W.S., Rush, W.L., Guinee, D.G., Caporaso, N.E., Welsh, J.A., Jones, R.T., Borkowski, A., Travis, W.D., Trastek, V., Pairolero, P.C., Tazelaar, H.F., Midthun, D., Jett, J.R., Liotta, L.A., and Harris, C.C.  p21waf1/cip1 and Transforming Growth Factor-beta-1 protein expression correlate with survival in non-small cell lung cancer. Clin.Cancer Res., 4: 1499-1506, 1998.

Ambs, S., Bennett, W.P., Merriam, W.G., Ogunfusika, M.O., Oser, S.M., Burke, L.M., Khan, M.A. and Harris, C.C.  Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Brit. J. Cancer, 78: 233-239, 1998.

Khan, M.A., Travis, L.B., Soini, Y., Welsh, J.A., Stovall, M., Clarke, E.A., Hunter, V., Boice, Jr., J.D., Tarone, R.E. and Bennett, W.P.  p53 mutations in cyclophosphamide-associated  bladder cancer.  Cancer Epi. Biomarkers & Prev., 7: 397-403, 1998.

Ambs, S., Merriam, W.G., Bennett, W.P., Felley-Bosco, E., Ogunfusika, M.O., Oser, S.M., Klein, S., Shields, P., Billiar, T.R., and Harris, C.C.  Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis & colon cancer progression. Cancer Res, 58:334-41, 1998.

Gemma, A., Hagiwara, K., Vincent, F., Ke, Y., Hancock, A.R., Nagashima, M., Bennett, W.P., and Harris, C.C.  hSMAD5 gene, a human SMAD family member: its full length cDNA, genomic structure, promoter region and mutation analysis in human tumors.  Oncogene, 16: 951-956, 1998.

Cawley, H.M., Meltzer, S.J., DeBenedetti, V.M.G., Hollstein, M.C., Muehlbauer, K.-R., Liang, L., Bennett, W.P., Souza, R.F., Greenwald, B.D., Cottrell, J., Salabes, A., Bartsch, H., Trivers, G.E.  Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis. Gastroenterology, 115:19-27, 1998.

Przygodzki, R.M., Khan, M.A., Guinee, D.G., Bennett, W.P., Shields, P.G., Travis, W.D., Jett, J., Colby, T., Tazelaar, H., Pairolero, P., Trastek, V., Liotta, L., Harris, C.C., Caporaso, N.E.  p53 Mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.  Pharmacogenetics, 8: 503-511, 1998.

Fleming, M.V., Guinee, D.G., Chu, W.S., Caporaso, N.E., Bennett, W.P., Jett, J., Abbondanzo, S.L., Colby, T., Tazelaar, H., Pairolero, P., Trastek, V., Liotta, L., Harris, C.C., Travis, W.D. Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients. Human Pathol., 29: 60-64, 1998.

Bennett, W.P.  SNPs, haplotypes, diseases & treatment.  Meeting Report on CHI “Implications of Human Genetic Variation,” October 1999, Boston. In: ID weekly highlights, ©Current Drugs, Ltd, 1999, 50: 44-47.

Bennett, W.P., Hussain, S.P., Vahakangas, K.H., Khan, M.A., Shields, P.G., Harris, C.C.  Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.  J. Pathol., 187: 8-18,1999.

Bennett, W.P., Alavanja, M.C.R. (co-first authors), Blomeke, B., Vähäkangas, K.H., Castren, K., Welsh, J.A., Bowman, E.D., Khan, M.A., Flieder, D.B., Harris, C.C.  Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women.  J.Natl.Cancer Inst., 91: 2009-14, 1999.

Rusin, M.R., Butkiewicz, D., Malusecka, E., Zborek, A., Harasim, J., Czyzewski, K., Bennett, W.P., Shields, P., Weston, A., Welsh, J., Krzyzowska, S., Chorazy, M., Harris, C.C.  Molecular epidemiological study of non-small cell lung cancer from an environmentally polluted region of Poland.  Brit. J. Cancer, 80: 1445-52, 1999.

Ambs, S., Bennett, W.P., Merriam, W.G., Ogunfusika, M.O., Oser, S.M., Harrington, A.M., Shields, P.G., Felley-Bosco, E., Hussain, S.P., and Harris, C.C.  Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer.  J.Natl.Cancer Inst., 91: 86-88, 1999.

Bennett, W.P., Hussain, S.P., Vähäkangas, K.H., Khan, M.A., Shields, P.G., Harris, C.C.  Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.  J. Pathol., 187: 8-18, 1999.

Bennett, W.P.  Cancer Susceptibility Genes: Germline Mutations & Polymorphisms Conferring High Risks of Neoplasia.  In: "DNA Alterations in Cancer: Genetic and Epigenetic Changes," Editor, Melanie Ehrlich; BioTechniques Books, Natick, MA, 2000.

Hussain, S.P., Amstad, P., Raja, K., Ambs, S., Nagashima, M., Bennett, W.P., Shields, P.G., Ham, A-J., Swenberg, J.A., Marrogi, A.J., Harris, C.C.  Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.  Cancer Res., 60: 3333-3337, 2000.

Smith, L.E., Denissenko, M.F., Bennett, W.P., Li, H., Amin, S., Tang, M.-S., Pfeifer, G.P. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J.Natl.Cancer Inst., 92:803-11, 2000.

Galateau-Salle, F.B., Luna, R.E., Horiba, K., Sheppard, M.N., Hayashi, T., Fleming, M.V., Colby, T.V., Bennett, W.P., Harris,C., Stetler-Stevenson,W., Liotta, L., Ferrans,V.J., Travis, W.D. Matrix metalloproteinases & tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions. Human Pathology 31:296-305, 2000.

Saito, T., Krutovskikh, V., Marion, M.-J., Ishak, K., Bennett, W.P., Yamasaki, H.  Human hemangiosarcomas have a common polymorphism but no mutations in the connexin 37 gene.  Int. J. Cancer, 86: 67-70, 2000.

Feng, J., Zheng, J., Bennett, W.P., Heston, L.L., Jones, I.R., Craddock, N., Sommer, S.S. Five missense variants in the amino-terminal domain of the glucocorticoid receptor: No association with puerperal psychosis or schizophrenia.  Am. J. Med. Genetics (Neuropsychiatric Genetics), 96: 412-417, 2000.

Bennett, W.P., Alavanja, M.C.R., Harris, C.C.  Response Re: Environmental tobacco smoke, genetic susceptibility & risk of lung cancer in never-smoking women. J. Natl. Cancer Inst. [letter], 92: 760-1, 2000

Vähäkangas, K.H., Bennett, W.P. (co-first authors), Castren, K., Welsh, J.A., Khan, M.A., Blomeke, B., Alavanja, M.C.R., Harris, C.C.  p53 and K-ras mutations in lung cancers from former and never-smoking women. Cancer Res., 61: 4350-56, 2001.

Feng, J., Zheng, J., Gelernter, J., Kranzler, H., Cook, E., Goldman, D., Jones, I.R., Craddock, N., Heston, L.L., Delisi, L., Peltonen, L., Bennett, W.P., Sommer, S.S.  An in-frame deletion in the 2CAdrenergic Receptor is common in African-Americans.  Molecular Psychiatry, 6: 168-172, 2001.

Sommer, S.S., Buzin, C.H., Jung, M., Zheng, J., Liu, Q., Jeong, S.J., Moulds, J., Nguyen, V.Q., Feng, J., Bennett, W.P., Dritschilo, A.  Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controls.  Cancer Genetics Cytogenet., 134: 25-32, 2002.

Burke, L., Flieder, D.B., Guinee, D.G., Brambilla, E., Freedman, A.N., Bennett, W.P., Jones, R.T., Borkowski, A., Caporaso, N.A., Fleming, M., Trastek, V., Pairolero, P., Tazelaar, H., Midthun, D., Jett, J.R., Liotta, L.A., Travis, W.D., Harris, C.C.  Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin. Cancer Res. 11: 232-41, 2005.

Bonner, M.R., Bennett, W.P. (co-first authors), Xiong, W., Lan, Q., Wright, M.E., Brownson, R.C., Harris, C.C., Field, R.W., Lubin, J.H., Alavanja, M.C.R.  Radon, environmental tobacco smoke, glutathione-s-transferase M1 and lung cancer in U.S. women.  Int. J. Cancer, 119: 1462-1467, 2006.

This is a partial list. Full publications list available upon request.  Information on this page may be self-reported. Last updated: 07/08.